Back-flipping, nunchuck-weilding humanoid robots delighted and amazed viewers at China’s annual televised new-year extravaganza with their kung-fu choreography. But they – and their rivals who took to ...
Four rising humanoid robot startups demonstrated their products at the annual CCTV Spring Festival gala, a televised event and touchstone for China akin to the Super Bowl.
The Vande Bharat chair car service offers fares of Rs 2.19 per kilometre, significantly lower than similar services in Japan, China and France which range from Rs 7 to Rs 20.
Yahoo Finance Tech Editor Dan Howley comes on Market Domination to break down the day's leading and trending tech stories. Nvidia (NVDA) is moving further into CPUs with its expanded Meta (META) deal, ...
Driving Innovation and Sustainability in the Sanitary Napkin Market with Advanced Manufacturing Solutions CALIFORNIA, ...
On January 16th (China time), GWM Group globally unveiled its native AI all-powertrain vehicle platform, “GWM ONE.” Reportedly, the “GWM ONE” platform is a core achievement of GWM Group’ adherence to ...
The tech-heavy index has closed in the red for five straight weeks, dragged down by concerns about big spending on AI as well as a series of panic selloffs that have hit industries including software, ...
Opinion
Campbell, Beg, Worah: The US needs a national fusion strategy before our lead in energy slips away
China, Europe and the U.K. have been pouring billions into fusion development. If the U.S. wants fusion energy to power our economy in the ...
Galgotias University removed from AI Summit for misrepresenting a robotic dog as its own innovation amid public backlash.
The French President’s visit, though coinciding with the AI Summit, will certainly focus on military-industrial cooperation, in which France is expected to help build India’s capacities and capabiliti ...
So, there’s this thing called the “Big Beautiful Bill” that’s been making waves, and it might seriously shake up how AI is ...
China’s brain-computer interface industry is rapidly scaling from research to commercialization, driven by strong policy support, expanding clinical trials, and growing investor interest.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results